Last Update

2016-04-29T00:00:00.000Z

This profile was last updated on .

Is this you? Claim your profile.

Wrong Steven Manoukian?

Dr. Steven V. Manoukian M.D.

Vice President, Cardiovascular Service Line; Operations and Service Lines Group (OSG)

HCA Inc.

Direct Phone: (615) ***-****       

Email: s***@***.com

Get ZoomInfo Grow

+ Get 10 Free Contacts a Month

Please agree to the terms and conditions

I agree to the Terms of Service and Privacy Policy. I understand that I will receive a subscription to ZoomInfo Community Edition at no charge in exchange for downloading and installing the ZoomInfo Contact Contributor utility which, among other features, involves sharing my business contacts as well as headers and signature blocks from emails that I receive.

HCA Inc.

One Park Plaza

Nashville, Tennessee 37203

United States

Company Description

HCA owns and operates approximately 179 hospitals and approximately 104 freestanding surgery centers in 21 states, England and Switzerland. We are dedicated to providing healthcare services that meet each community's local healthcare needs. We seek to int ... more

Find other employees at this company (28,852)

Background Information

Employment History

Director of Cardiovascular Research

Sarah Cannon Research Institute

Interventional and Preventive Cardiologist

Emory University

Physician

Centennial Heart

Affiliations

Board Member
Greater Nashville AHA

Member of the Faculty
Transcatheter Cardiovascular Therapeutics

Fellow
Society for Cardiovascular Angiography and Interventions

Fellow
American College of Cardiology

Founder
Stronger Hearts Helpline

Member
Strategic Health Initiatives Committee

Education

Emory University School of Medicine

M.D.

MD

Emory

medical degree

New York University

medical degree

New York University School of Medicine

undergraduate degree

Saint John's University

Web References (189 Total References)


Steven Manoukian, M.D., vice ...

healthtrustpg.com [cached]

Steven Manoukian, M.D., vice president of HCA's cardiovascular service line, agrees that CardioMEMS is a potential game-changer that could dramatically improve clinical outcomes. He adds that a number of HCA facilities have started implanting the CardioMEMS device in heart failure patients.

"Data measured by a CardioMEMS device traditionally required an invasive procedure performed in the intensive care unit of a hospital," Manoukian says.
...
- Steven Manoukian, M.D., vice president of HCA's cardiovascular service line
For instance, Manoukian highlights the importance of patient education in boosting compliance with medications, follow-up and dietary guidelines. As part of the National Forum for Heart Disease and Stroke Prevention's Stronger Hearts Partnership, he helped establish the Stronger Hearts Helpline, which provides 24-hour information to educate patients on heart failure and referrals to community resources.
...
In addressing variation, Manoukian says HCA focuses on standardizing processes across the organization, which can improve outcomes by raising the level of care for all patients.
"What we're attempting to do is to ensure that all of our facilities have an overall process on how to best manage heart failure patients within their community," he says.
Manoukian explains that while some facilities offer comprehensive cardiovascular programs complete with board-certified heart failure and transplantation specialists, other hospitals with general cardiologists-or those without a cardiologist on staff at all-may not be as experienced in managing heart failure.
"It's really about educating practitioners who might see a heart failure patient," he says, pointing out that this also includes primary care providers and emergency department physicians.


KEYNOTE: improving Quality of care in ...

www.shmconference.com [cached]

KEYNOTE: improving Quality of care in America : 2008 & Beyond - Steven Manoukian, MD, FACC, FSCAI


Clinical Leadership New

sarahcannonresearch.com [cached]

Steven Manoukian, M.D., F.A.C.C., F.S.C.A.I. Director, Cardiovascular Research

Before joining SCRI as director of cardiovascular research, Dr. Manoukian served as director of interventional cardiology at Emory University Hospital Midtown in Atlanta and as faculty member at Emory University School of Medicine for 15 years. He is active in interventional research, particularly regarding the efficacy and safety of antithrombin and antiplatelet therapy. He received his medical degree from New York University School of Medicine and completed his residency and chief residency at the State University of New York at Stony Brook. He then completed his cardiology and interventional cardiology fellowships at Emory University School of Medicine. He received the Emory University Cardiovascular Fellowship Excellence in Teaching Award and was selected as one of the Best Doctors in America. He is a chair of the Tennessee Cardiac Systems of Care Task Force, past President of the Atlanta Division American Heart Association, member of the board of directors of the Greater Southeast Affiliate - AHA, member of the Strategic Health Initiatives Committee and chairman of the STEMI Task Force.


Cardiovascular New

www.sarahcannonresearch.com [cached]

Steven Manoukian, M.D., F.A.C.C., F.S.C.A.I. Director, Cardiovascular Research SCRI

Steven V. Manoukian, MD, FACC, FSCAI, serves as director of cardiovascular research, Sarah Cannon Research Institute; medical director of cardiology, Clinical Services Group (CSG), Hospital Corporation of America (HCA), Inc; and interventional cardiologist, Centennial Heart Center; all in Nashville, Tennessee. Prior to these roles, he held the position of director of interventional cardiology, Emory University Hospital Midtown in Atlanta; and faculty member, Emory University School of Medicine, for 15 years.
Dr. Manoukian is active in interventional research, particularly regarding the efficacy and safety of antithrombin and antiplatelet therapy (myocardial infarction, acute coronary syndromes, and percutaneous coronary intervention). A primary area of his interest relates to improving outcomes by minimizing the risk of bleeding in these scenarios through a better understanding of the patient, procedural, and treatment factors which are associated with bleeding complications. These include anemia, transfusion, age, chronic kidney disease, gender, vascular complications and access, and differences between pharmacologic agents, etc. He has served on the leadership committees of numerous trials.
His papers, reviews, book chapters, and editorials have been published widely in journals such as Circulation, Journal of the American College of Cardiology, American Journal of Cardiology, Journal of the American Medical Association, European Heart Journal, and Lancet. He is a member of the faculty of the Transcatheter Cardiovascular Therapeutics (TCT), American Heart Association (AHA), American College of Cardiology (ACC), Cardiovascular Revascularization Therapies (CRT) scientific sessions, Emory Practical Intervention Course (EPIC), and numerous other national and international meetings. He is on the editorial board and/or a reviewer for several medical journals.
Dr. Manoukian received his medical degree from New York University School of Medicine. He completed his residency and chief residency at the State University of New York at Stony Brook, and completed his cardiology and interventional cardiology fellowships at Emory University School of Medicine. He has received the Emory University Cardiovascular Fellowship Excellence in Teaching Award and was selected as one of the Best Doctors in America. He has worked as a medical reporter for FOX television news in Atlanta. He is a chair of the Tennessee Cardiac Systems of Care Task Force, past President of the Atlanta Division American Heart Association, member of the board of directors of the Greater Southeast Affiliate - AHA (encompassing Tennessee, Georgia, Florida, Alabama, Mississippi, Louisiana, U.S.V.I., and Puerto Rico), member of the Strategic Health Initiatives Committee, and chairman of the STEMI Task Force.


Cardiovascular New

sarahcannonresearch.com [cached]

Steven Manoukian, M.D., F.A.C.C., F.S.C.A.I. Director, Cardiovascular Research SCRI

Steven V. Manoukian, MD, FACC, FSCAI, serves as director of cardiovascular research, Sarah Cannon Research Institute; medical director of cardiology, Clinical Services Group (CSG), Hospital Corporation of America (HCA), Inc; and interventional cardiologist, Centennial Heart Center; all in Nashville, Tennessee. Prior to these roles, he held the position of director of interventional cardiology, Emory University Hospital Midtown in Atlanta; and faculty member, Emory University School of Medicine, for 15 years.
Dr. Manoukian is active in interventional research, particularly regarding the efficacy and safety of antithrombin and antiplatelet therapy (myocardial infarction, acute coronary syndromes, and percutaneous coronary intervention). A primary area of his interest relates to improving outcomes by minimizing the risk of bleeding in these scenarios through a better understanding of the patient, procedural, and treatment factors which are associated with bleeding complications. These include anemia, transfusion, age, chronic kidney disease, gender, vascular complications and access, and differences between pharmacologic agents, etc. He has served on the leadership committees of numerous trials.
His papers, reviews, book chapters, and editorials have been published widely in journals such as Circulation, Journal of the American College of Cardiology, American Journal of Cardiology, Journal of the American Medical Association, European Heart Journal, and Lancet. He is a member of the faculty of the Transcatheter Cardiovascular Therapeutics (TCT), American Heart Association (AHA), American College of Cardiology (ACC), Cardiovascular Revascularization Therapies (CRT) scientific sessions, Emory Practical Intervention Course (EPIC), and numerous other national and international meetings. He is on the editorial board and/or a reviewer for several medical journals.
Dr. Manoukian received his medical degree from New York University School of Medicine. He completed his residency and chief residency at the State University of New York at Stony Brook, and completed his cardiology and interventional cardiology fellowships at Emory University School of Medicine. He has received the Emory University Cardiovascular Fellowship Excellence in Teaching Award and was selected as one of the Best Doctors in America. He has worked as a medical reporter for FOX television news in Atlanta. He is a chair of the Tennessee Cardiac Systems of Care Task Force, past President of the Atlanta Division American Heart Association, member of the board of directors of the Greater Southeast Affiliate - AHA (encompassing Tennessee, Georgia, Florida, Alabama, Mississippi, Louisiana, U.S.V.I., and Puerto Rico), member of the Strategic Health Initiatives Committee, and chairman of the STEMI Task Force.

Similar Profiles

Other People with this Name

Other people with the name Manoukian

Daniel Manoukian
Fitness Clinic Pty Ltd

Mark Manoukian
Kegler , Brown , Hill & Ritter

Ani Manoukian
Armenian General Benevolent Union

Stan Manoukian
Boleta & Amaneet

Vartan Manoukian
The Traffic Lawyers

Browse ZoomInfo's Business Contact Directory by City

Browse ZoomInfo's
Business People Directory

Browse ZoomInfo's
Advanced Company Directory